Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (9900)	1/1/2004 3:53:12 AM
From: Icebrg	Read Replies (1) \| Respond to of 52153

>>I saw that Rick on the NBIX board has nominated Gary Lynch for another CEO of the year award.>> Whenever I suggest Gary Lynch, think Gary Lyons. Unless the subject at hand is Cortex (COR) or AMPA-kines and/or -receptors. Thanks to sales who was kind enough to point out my mistake in a PM. Erik

To: Icebrg who wrote (9900)	1/1/2004 12:14:18 PM
From: jayhawk969	Read Replies (1) \| Respond to of 52153

The reason for my nomination is mainly the company's recent announcement that they have started four phase IIIb studies of ESTORRA enrolling in total 2.300 persons, before they have even seen FDA approve their still outstanding NDA Probably because the anticipate an "approvable" letter -- getting a head start on anticipated additional testing.